Using Feedback Reports to Improve Medication Adherence
| Status: | Completed |
|---|---|
| Conditions: | Peripheral Vascular Disease, Cardiology |
| Therapuetic Areas: | Cardiology / Vascular Diseases |
| Healthy: | No |
| Age Range: | 30 - 75 |
| Updated: | 2/1/2018 |
| Start Date: | January 2014 |
| End Date: | September 3, 2015 |
Evaluating Individual and Patient-Selected Family/Friend/or Reciprocal Peer Notifications to Improve Statin Medication Adherence Among Patients With Coronary Artery Disease
The purpose of this research study is to improve statin medication adherence among Veterans
with coronary artery disease with poor adherence to medications. The investigators are
testing if newer technology pill bottle devices linked with individual feedback and/or social
incentive strategies can improve medication taking behavior.
with coronary artery disease with poor adherence to medications. The investigators are
testing if newer technology pill bottle devices linked with individual feedback and/or social
incentive strategies can improve medication taking behavior.
Patients with coronary artery disease and previous poor adherence to statin medications will
be recruited at Philadelphia VA Medical Center. Enrolled participants will be randomly
assigned to one of three arms:
1. Control Group
2. Individual Alarm device and feedback report
3. Individual plus patient-selected Feedback Friend report
Patients will be given a medication-monitoring device (Vitality GlowCaps) to monitor the
statin medication that is being currently prescribed by their primary care physician. In
first group, the control arm (Arm 1), the device reminders will be turned off but the device
will continue recording adherence to the medications. In second group, reminder arm (Arm 2),
the device will be programmed as an alarm that will be activated if the patient does not take
the medication at the time set by the patient. In addition the patient will get a weekly
report of his/her adherence. In the third group, patient-selected family/friend/or reciprocal
peer feedback arm (Arm 3), in addition to the activation of the alarm function the device
will be linked to a weekly report on adherence to medications. This report will be delivered
to the patient and to the patient identified family/friend/ or reciprocal peer.
be recruited at Philadelphia VA Medical Center. Enrolled participants will be randomly
assigned to one of three arms:
1. Control Group
2. Individual Alarm device and feedback report
3. Individual plus patient-selected Feedback Friend report
Patients will be given a medication-monitoring device (Vitality GlowCaps) to monitor the
statin medication that is being currently prescribed by their primary care physician. In
first group, the control arm (Arm 1), the device reminders will be turned off but the device
will continue recording adherence to the medications. In second group, reminder arm (Arm 2),
the device will be programmed as an alarm that will be activated if the patient does not take
the medication at the time set by the patient. In addition the patient will get a weekly
report of his/her adherence. In the third group, patient-selected family/friend/or reciprocal
peer feedback arm (Arm 3), in addition to the activation of the alarm function the device
will be linked to a weekly report on adherence to medications. This report will be delivered
to the patient and to the patient identified family/friend/ or reciprocal peer.
Inclusion Criteria:
- All participants will have a diagnosis of CAD
- To be eligible they must be between the ages of 30-75 years of age-to ensure we are
targeting those most likely to benefit from improving control to these medications
- Patients must have been prescribed a statin by their provider and a documented poor
adherence as measured by a 16-month medication adherence rate (Medication Possession
Ratio) of <80%
Exclusion Criteria:
- Due to the use of the medication adherence reminder device, patients must speak
English
- Have a home address
- Telephone number
- Be willing and able to identify a friend or family member
- The investigators will exclude atients with active substance abuse, significant
hearing loss, or reduced cognitive ability as determined from the patient's problem
list
We found this trial at
1
site
Click here to add this to my saved trials
